Our goal remains the same: To bring delicious pastries to the people in Singapore," he asserts diplomatically. He clarifies that while Le Matin’s Ion Orchard cafe is closed, the pastry brand still ...
Dubai, United Arab Emirates, Nov. 11, 2024 (GLOBE NEWSWIRE) -- The 2024 Crypto Content Creator Campus (CCCC), a landmark event to shape the future of the content creator economy, officially commenced ...
All they went by were gentlemen’s agreements when it came to settling on a certain place and time to meet. For a trip down memory lane, here are some of the most iconic meet-up spots in Singapore that ...
SINGAPORE - Artificial intelligence (AI) development will get a boost with the signing of a new memorandum of cooperation between Singapore and Britain to enhance the safety and reliability of AI ...
THE export-driven Singapore economy is bracing for the likelihood of higher tariffs globally as Donald Trump returns to the White House to serve a second term as US president, four years after Joe ...
Stifel Nicolaus analyst Bradley Canino maintained a Buy rating on C4 Therapeutics (CCCC – Research Report) today and set a price target of $14.00. The company’s shares closed yesterday at $6.09.
SINGAPORE – Days after Punggol resident Gordon Hoo moved into his landed home in Ponggol Twenty-Fourth Avenue in November 2023, a troop of monkeys showed up and climbed up and down his fence and ...
MEXC is proud to partner with the inaugural Crypto Content Creator Campus CCCC event, taking place this November in Dubai. This momentous occasion is dedicated to exploring the depth and breadth of ...
We are often on the hunt for the best deals in Singapore, but sometimes we just don’t have the right lobangs or resources to know where to look. Grocery shopping is a big part of our lives, and we can ...
An icon in the shape of a lightning bolt. Impact Link Singapore Airlines plans to spend more than $800 million to retrofit its long-haul planes as customers demand more luxury at 35,000 feet.
Morgan Stanley analyst Terence Flynn maintained a Hold rating on C4 Therapeutics (CCCC – Research Report) today and set a price target of $8.00. The company’s shares closed last Friday at $5.61.